InvestorMulti-strategy private equity firm with a global presence.

Pappas Capital is a venture capital and commercial development firm based in Durham, North Carolina, specializing in the life sciences sector. The firm invests in biotechnology, biopharmaceuticals, and medical devices, focusing on advancing scientific discoveries from concept to commercialization.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Pappas Capital, founded in 1994, is a global venture capital and commercial development firm headquartered in Durham, North Carolina. The organization focuses on investing in next-generation life science, agriculture, and technology companies. It operates three primary lines of business: Pappas Ventures, its flagship life science venture arm; Specialized Fund Management, which creates and manages custom investment vehicles; and Translational Medicine, which partners with research universities to accelerate the development of scientific discoveries. With a commitment to advancing life science innovations, Pappas Capital has invested in over 100 companies, targeting opportunities across various stages of development.
Pappas Capital invests in the life science sector, including biotechnology, biopharmaceuticals, drug delivery, and medical devices. The firm targets opportunities across various stages, from seed stage to later-stage mezzanine transactions, with a particular interest in companies at Phase 1 or Phase 2 of development. The organization emphasizes strong proprietary positions, well-defined markets, and effective management teams.
Pappas Capital adds value to its portfolio companies through strategic partnerships, particularly with academic institutions, to accelerate the development of innovative technologies. The firm not only provides capital but also engages in co-founding and launching companies, leveraging its extensive network and expertise in the life sciences sector.
Pappas Capital focuses on innovative life science, agriculture, and technology companies. They seek opportunities across various stages, particularly in companies at Phase 1 or Phase 2 of development. The firm emphasizes strong proprietary positions, well-defined markets, and effective management teams.
Founders can reach out through the firm's website or contact them directly via phone. A well-prepared pitch deck should include details about the technology, market opportunity, and team. Pappas Capital values clear communication and a strong understanding of the competitive landscape.
Pappas Capital's unique approach includes three lines of business: Pappas Ventures, Specialized Fund Management, and Translational Medicine. This structure allows them to tailor investments and partnerships effectively, particularly with academic institutions, to accelerate scientific advancements.
The firm invests primarily in the United States, Canada, and Asia, targeting innovative companies in these regions.
Pappas Capital invests across various stages, with check sizes varying based on the specific needs of the company and the stage of development. They are known to participate in seed stage to later-stage mezzanine transactions.
Pappas Capital provides operational support, mentorship, and access to their extensive network within the life sciences community. They actively engage with portfolio companies to help them achieve their goals and enhance their market position.
Superscout Pro
Is this page right?Reviewed · How the research works